• Nanologica's board on October 23, 2026, resolved on a rights issue of approximately SEK 110.5 million.
• The rights issue is 77.6% guaranteed. The subscription period runs November 3–17, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanologica AB published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.